SCHEMBL17876244

SCHEMBL17876244

c1ccc(N2Cc3cc(-c4ccc5oc6ccccc6c5c4)ccc3-c3cc(-c4cccc5oc6ccccc6c45)ccc3C2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 6/20 0.34
ALOX5 P09917 1/20 0.33
FAAH O00519 1/20 0.33
HSP90AA1 P07900 1/20 0.32
HSP90AB1 P08238 1/20 0.32
PLA2G2A P14555 2/20 0.32
PLA2G4A P47712 2/20 0.32
PLA2G10 O15496 1/20 0.32
MAPT P10636 3/20 0.32
MMP8 P22894 2/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 2/20 0.32
HPGD P15428 2/20 0.32
KMT2A Q03164 2/20 0.32
MMP3 P08254 1/20 0.32
ALDH1A1 P00352 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
BACE1 P56817 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876250 1.00 PRKDC (0.34) PRKDCALOX5FAAHHSP90AA1HSP90AB1
SCHEMBL17876305 0.96 PRKDC (0.36) PRKDCALOX5FAAHHSP90AA1HSP90AB1
SCHEMBL17876253 0.95 MAPT (0.35) PRKDCALOX5FAAHMAPTNPC1
SCHEMBL17876252 0.94 PRKDC (0.40) PRKDCALOX5FAAHMAPTNPC1
SCHEMBL17876237 0.94 PRKDC (0.40) PRKDCALOX5FAAHMAPTNPC1
SCHEMBL17876243 0.92 MAPT (0.36) PRKDCHSP90AA1HSP90AB1PLA2G2APLA2G4A
SCHEMBL17876254 0.92 PRKDC (0.37) PRKDCALOX5PLA2G2APLA2G4APLA2G10
SCHEMBL17876261 0.92 PRKDC (0.37) PRKDCALOX5PLA2G2APLA2G4APLA2G10
SCHEMBL17876228 0.91 ALOX5 (0.45) PRKDCALOX5MAPTKDM4EMEN1
SCHEMBL17876251 0.91 ALOX5 (0.45) PRKDCALOX5MAPTKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 PRKDC 4858/4885ALOX5 3059/4885FAAH 2524/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 PRKDC 4858/4885ALOX5 3059/4885FAAH 2524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.